| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Premature Birth | 17 | 2021 | 2151 | 2.88 | Why? |
| Obstetrics | 7 | 2020 | 859 | 2.20 | Why? |
| Obstetric Labor, Premature | 3 | 2020 | 114 | 1.33 | Why? |
| Prenatal Care | 6 | 2020 | 1314 | 1.29 | Why? |
| Respiratory Distress Syndrome, Newborn | 2 | 2018 | 124 | 1.24 | Why? |
| Pregnancy Complications, Infectious | 20 | 2021 | 11559 | 1.01 | Why? |
| Pregnancy | 44 | 2021 | 23879 | 1.00 | Why? |
| Pre-Eclampsia | 3 | 2020 | 599 | 0.97 | Why? |
| Pregnancy Outcome | 10 | 2021 | 3803 | 0.90 | Why? |
| Maternal Age | 4 | 2021 | 244 | 0.88 | Why? |
| Gestational Age | 12 | 2020 | 1488 | 0.80 | Why? |
| Fetal Membranes, Premature Rupture | 2 | 2018 | 122 | 0.80 | Why? |
| Hypertension, Pregnancy-Induced | 3 | 2021 | 208 | 0.79 | Why? |
| Postpartum Hemorrhage | 2 | 2020 | 144 | 0.69 | Why? |
| Birth Injuries | 1 | 2017 | 6 | 0.69 | Why? |
| Pregnancy, Multiple | 1 | 2017 | 46 | 0.69 | Why? |
| Vaginal Birth after Cesarean | 1 | 2017 | 16 | 0.68 | Why? |
| Cerebral Palsy | 1 | 2018 | 156 | 0.66 | Why? |
| Maternal Death | 1 | 2018 | 108 | 0.65 | Why? |
| Uterus | 1 | 2017 | 98 | 0.64 | Why? |
| Perineum | 1 | 2017 | 70 | 0.64 | Why? |
| Hysterectomy | 1 | 2018 | 171 | 0.64 | Why? |
| Infant Mortality | 2 | 2018 | 268 | 0.63 | Why? |
| Obstetric Labor Complications | 1 | 2017 | 119 | 0.61 | Why? |
| Infant, Small for Gestational Age | 1 | 2016 | 151 | 0.61 | Why? |
| Pregnancy Complications, Cardiovascular | 2 | 2020 | 231 | 0.59 | Why? |
| Infant, Newborn | 20 | 2021 | 23105 | 0.57 | Why? |
| Infant, Premature | 2 | 2018 | 883 | 0.56 | Why? |
| Birth Weight | 1 | 2016 | 250 | 0.56 | Why? |
| Prenatal Exposure Delayed Effects | 1 | 2018 | 319 | 0.54 | Why? |
| Perinatal Care | 1 | 2020 | 576 | 0.53 | Why? |
| Gynecology | 1 | 2020 | 741 | 0.48 | Why? |
| Fellowships and Scholarships | 1 | 2020 | 931 | 0.46 | Why? |
| New York City | 14 | 2021 | 7432 | 0.44 | Why? |
| Zika Virus Infection | 3 | 2019 | 1920 | 0.43 | Why? |
| Adrenal Cortex Hormones | 2 | 2018 | 6537 | 0.42 | Why? |
| Emigrants and Immigrants | 1 | 2019 | 888 | 0.41 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.40 | Why? |
| Infectious Disease Transmission, Vertical | 4 | 2021 | 5164 | 0.40 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2018 | 994 | 0.38 | Why? |
| Delivery, Obstetric | 2 | 2021 | 1292 | 0.36 | Why? |
| Pregnancy Complications | 5 | 2020 | 1388 | 0.36 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.36 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2018 | 1671 | 0.34 | Why? |
| Brain Diseases | 1 | 2019 | 1463 | 0.33 | Why? |
| Zika Virus | 1 | 2019 | 1924 | 0.31 | Why? |
| New York | 3 | 2020 | 2488 | 0.31 | Why? |
| Cesarean Section | 7 | 2021 | 2089 | 0.30 | Why? |
| Female | 46 | 2021 | 380317 | 0.29 | Why? |
| Research | 1 | 2017 | 2115 | 0.28 | Why? |
| Healthcare Disparities | 2 | 2018 | 3893 | 0.25 | Why? |
| Personnel Staffing and Scheduling | 3 | 2021 | 1578 | 0.24 | Why? |
| Labor, Induced | 2 | 2020 | 186 | 0.23 | Why? |
| Residence Characteristics | 3 | 2021 | 1927 | 0.22 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.21 | Why? |
| Baths | 1 | 2020 | 62 | 0.21 | Why? |
| Dominican Republic | 1 | 2019 | 57 | 0.20 | Why? |
| Breast Feeding | 2 | 2021 | 1585 | 0.20 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.20 | Why? |
| Pregnancy, High-Risk | 1 | 2020 | 128 | 0.19 | Why? |
| Pregnancy, Twin | 2 | 2019 | 133 | 0.19 | Why? |
| Internship and Residency | 1 | 2020 | 4987 | 0.19 | Why? |
| Delivery Rooms | 1 | 2020 | 148 | 0.19 | Why? |
| Progestins | 1 | 2018 | 43 | 0.18 | Why? |
| New Jersey | 1 | 2020 | 528 | 0.18 | Why? |
| Uterine Cervical Incompetence | 1 | 2017 | 7 | 0.18 | Why? |
| Fusobacterium nucleatum | 1 | 2018 | 28 | 0.18 | Why? |
| Humans | 47 | 2021 | 930598 | 0.18 | Why? |
| Cerclage, Cervical | 1 | 2017 | 17 | 0.18 | Why? |
| Health Status Disparities | 4 | 2020 | 4072 | 0.17 | Why? |
| Parity | 1 | 2018 | 122 | 0.17 | Why? |
| Fusobacterium Infections | 1 | 2018 | 37 | 0.17 | Why? |
| Research Subjects | 1 | 2020 | 178 | 0.17 | Why? |
| Femur | 1 | 2018 | 100 | 0.17 | Why? |
| Infant, Premature, Diseases | 1 | 2018 | 74 | 0.17 | Why? |
| Obstetrics and Gynecology Department, Hospital | 1 | 2021 | 241 | 0.17 | Why? |
| Transient Tachypnea of the Newborn | 1 | 2016 | 2 | 0.17 | Why? |
| Maternal Mortality | 2 | 2021 | 461 | 0.17 | Why? |
| Cerebral Intraventricular Hemorrhage | 1 | 2016 | 4 | 0.17 | Why? |
| Glucose Tolerance Test | 1 | 2018 | 238 | 0.17 | Why? |
| Perinatal Death | 2 | 2017 | 372 | 0.16 | Why? |
| Diabetes, Gestational | 2 | 2019 | 426 | 0.16 | Why? |
| Cervix Uteri | 1 | 2017 | 146 | 0.16 | Why? |
| Bronchopulmonary Dysplasia | 1 | 2016 | 53 | 0.16 | Why? |
| Head | 1 | 2018 | 206 | 0.16 | Why? |
| Enterocolitis, Necrotizing | 1 | 2016 | 71 | 0.16 | Why? |
| Twins | 1 | 2017 | 115 | 0.16 | Why? |
| Puerperal Disorders | 1 | 2018 | 151 | 0.16 | Why? |
| Microcephaly | 1 | 2018 | 181 | 0.16 | Why? |
| Prediabetic State | 1 | 2018 | 200 | 0.15 | Why? |
| Fetal Growth Retardation | 1 | 2018 | 217 | 0.15 | Why? |
| Cicatrix | 1 | 2017 | 129 | 0.15 | Why? |
| Indians, North American | 1 | 2018 | 195 | 0.15 | Why? |
| Telemedicine | 4 | 2020 | 25032 | 0.14 | Why? |
| Adult | 23 | 2021 | 244371 | 0.14 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.14 | Why? |
| Patient Selection | 2 | 2020 | 4560 | 0.14 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.14 | Why? |
| Asian Americans | 1 | 2018 | 387 | 0.13 | Why? |
| Transportation | 1 | 2020 | 691 | 0.13 | Why? |
| Young Adult | 12 | 2021 | 93724 | 0.13 | Why? |
| Carrier State | 3 | 2021 | 2100 | 0.13 | Why? |
| Patient Safety | 2 | 2020 | 4885 | 0.13 | Why? |
| Patient Acuity | 1 | 2021 | 1755 | 0.13 | Why? |
| African Americans | 2 | 2019 | 3363 | 0.12 | Why? |
| Text Messaging | 1 | 2017 | 389 | 0.12 | Why? |
| Social Class | 1 | 2020 | 1360 | 0.11 | Why? |
| Reproductive Health | 1 | 2017 | 473 | 0.11 | Why? |
| United States | 8 | 2021 | 46150 | 0.11 | Why? |
| Postpartum Period | 1 | 2018 | 936 | 0.11 | Why? |
| Linear Models | 1 | 2018 | 1914 | 0.11 | Why? |
| Telephone | 1 | 2020 | 1705 | 0.11 | Why? |
| Academic Medical Centers | 2 | 2020 | 3088 | 0.11 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.11 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.11 | Why? |
| Placenta | 1 | 2021 | 1531 | 0.11 | Why? |
| Mothers | 1 | 2021 | 1624 | 0.10 | Why? |
| Intersectoral Collaboration | 1 | 2017 | 1065 | 0.10 | Why? |
| Primary Prevention | 1 | 2017 | 778 | 0.10 | Why? |
| Research Personnel | 1 | 2020 | 1037 | 0.10 | Why? |
| Electronic Health Records | 2 | 2020 | 3492 | 0.10 | Why? |
| Patient Care Team | 2 | 2021 | 3556 | 0.10 | Why? |
| Logistic Models | 3 | 2021 | 9089 | 0.10 | Why? |
| Delivery of Health Care, Integrated | 1 | 2021 | 1549 | 0.09 | Why? |
| Continuity of Patient Care | 1 | 2019 | 1574 | 0.09 | Why? |
| Maternal Health Services | 1 | 2017 | 808 | 0.09 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.09 | Why? |
| Intensive Care Units | 5 | 2021 | 29594 | 0.09 | Why? |
| Congresses as Topic | 1 | 2017 | 1347 | 0.09 | Why? |
| Videoconferencing | 1 | 2020 | 2081 | 0.09 | Why? |
| Seizures | 1 | 2016 | 1163 | 0.08 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Curriculum | 1 | 2020 | 3083 | 0.08 | Why? |
| Databases, Factual | 2 | 2018 | 6248 | 0.08 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.08 | Why? |
| Health Services Needs and Demand | 1 | 2021 | 3419 | 0.08 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.07 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.07 | Why? |
| Polymerase Chain Reaction | 1 | 2019 | 6740 | 0.07 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.07 | Why? |
| Ultrasonography, Prenatal | 2 | 2018 | 471 | 0.06 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.06 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.06 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 7868 | 0.06 | Why? |
| Ultrasonography | 1 | 2019 | 4409 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.06 | Why? |
| Mass Screening | 2 | 2020 | 8005 | 0.06 | Why? |
| Oxygen Inhalation Therapy | 3 | 2020 | 3629 | 0.06 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.06 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.06 | Why? |
| Chorioamnionitis | 1 | 2021 | 50 | 0.06 | Why? |
| Brain | 1 | 2019 | 5133 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2019 | 9091 | 0.06 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.05 | Why? |
| Rooming-in Care | 1 | 2020 | 53 | 0.05 | Why? |
| Uterine Inertia | 1 | 2020 | 13 | 0.05 | Why? |
| Nicardipine | 1 | 2020 | 13 | 0.05 | Why? |
| Bronchial Spasm | 1 | 2020 | 13 | 0.05 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.05 | Why? |
| Students, Medical | 1 | 2020 | 4032 | 0.05 | Why? |
| Workflow | 2 | 2021 | 2373 | 0.05 | Why? |
| Pregnant Women | 3 | 2020 | 2535 | 0.05 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2020 | 6166 | 0.05 | Why? |
| Influenza Vaccines | 1 | 2017 | 2941 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.05 | Why? |
| Prospective Studies | 4 | 2020 | 43301 | 0.05 | Why? |
| HELLP Syndrome | 1 | 2020 | 52 | 0.05 | Why? |
| Fetal Monitoring | 1 | 2020 | 80 | 0.05 | Why? |
| Perinatal Mortality | 1 | 2021 | 120 | 0.05 | Why? |
| Multi-Institutional Systems | 1 | 2020 | 97 | 0.05 | Why? |
| Pregnancy in Diabetics | 1 | 2020 | 56 | 0.05 | Why? |
| Tachypnea | 1 | 2020 | 197 | 0.05 | Why? |
| Male | 6 | 2021 | 367725 | 0.05 | Why? |
| Enzyme Inhibitors | 2 | 2020 | 1881 | 0.05 | Why? |
| Sepsis | 1 | 2016 | 3517 | 0.05 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.05 | Why? |
| Hypercapnia | 1 | 2020 | 172 | 0.05 | Why? |
| Sex Factors | 1 | 2016 | 11014 | 0.05 | Why? |
| Cephalometry | 1 | 2018 | 41 | 0.05 | Why? |
| Facility Design and Construction | 1 | 2020 | 189 | 0.05 | Why? |
| Evaluation Studies as Topic | 1 | 2020 | 391 | 0.05 | Why? |
| Transitional Care | 1 | 2020 | 135 | 0.05 | Why? |
| Fever | 3 | 2021 | 7795 | 0.04 | Why? |
| Infant | 2 | 2018 | 30274 | 0.04 | Why? |
| Ceftriaxone | 1 | 2020 | 365 | 0.04 | Why? |
| Cervical Length Measurement | 1 | 2017 | 38 | 0.04 | Why? |
| Genetic Counseling | 1 | 2020 | 229 | 0.04 | Why? |
| Anthropometry | 1 | 2018 | 233 | 0.04 | Why? |
| Prenatal Diagnosis | 1 | 2020 | 345 | 0.04 | Why? |
| Labor, Obstetric | 1 | 2020 | 257 | 0.04 | Why? |
| Organ Size | 1 | 2018 | 384 | 0.04 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.04 | Why? |
| Postnatal Care | 1 | 2020 | 346 | 0.04 | Why? |
| Periodontal Diseases | 1 | 2018 | 87 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Infant, Low Birth Weight | 1 | 2017 | 243 | 0.04 | Why? |
| Injections, Intramuscular | 1 | 2018 | 800 | 0.04 | Why? |
| Hospitals, Community | 1 | 2020 | 475 | 0.04 | Why? |
| Hypoxia | 2 | 2020 | 3626 | 0.04 | Why? |
| Anesthesia, General | 1 | 2020 | 470 | 0.04 | Why? |
| Medicaid | 1 | 2020 | 492 | 0.04 | Why? |
| Fluid Therapy | 1 | 2020 | 628 | 0.04 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.04 | Why? |
| Organizational Policy | 1 | 2020 | 694 | 0.04 | Why? |
| Central Nervous System Diseases | 1 | 2020 | 410 | 0.04 | Why? |
| Population Density | 1 | 2020 | 694 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Azithromycin | 2 | 2020 | 3943 | 0.04 | Why? |
| Mouth Mucosa | 1 | 2018 | 323 | 0.04 | Why? |
| Models, Organizational | 1 | 2021 | 908 | 0.03 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.03 | Why? |
| Myalgia | 1 | 2020 | 1015 | 0.03 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.03 | Why? |
| Crowding | 1 | 2020 | 731 | 0.03 | Why? |
| Family Planning Services | 1 | 2017 | 236 | 0.03 | Why? |
| Furin | 1 | 2021 | 1054 | 0.03 | Why? |
| Fetal Death | 1 | 2017 | 390 | 0.03 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.03 | Why? |
| Unemployment | 1 | 2020 | 702 | 0.03 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.03 | Why? |
| Research Support as Topic | 1 | 2017 | 327 | 0.03 | Why? |
| Risk Management | 1 | 2021 | 1044 | 0.03 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.03 | Why? |
| Influenza, Human | 1 | 2017 | 10779 | 0.03 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.03 | Why? |
| Health Services Research | 1 | 2017 | 756 | 0.03 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.03 | Why? |
| Income | 1 | 2020 | 1564 | 0.03 | Why? |
| Cardiomyopathies | 1 | 2020 | 997 | 0.03 | Why? |
| Virulence | 1 | 2018 | 2172 | 0.03 | Why? |
| Needs Assessment | 1 | 2021 | 2352 | 0.03 | Why? |
| Glycated Hemoglobin A | 1 | 2018 | 1316 | 0.03 | Why? |
| Travel-Related Illness | 1 | 2018 | 1357 | 0.03 | Why? |
| Acute Kidney Injury | 2 | 2020 | 5762 | 0.02 | Why? |
| Nucleocapsid Proteins | 1 | 2021 | 3120 | 0.02 | Why? |
| Taste Disorders | 1 | 2020 | 1720 | 0.02 | Why? |
| Middle Aged | 4 | 2020 | 270681 | 0.02 | Why? |
| Anti-Bacterial Agents | 2 | 2020 | 10083 | 0.02 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.02 | Why? |
| Qualitative Research | 1 | 2020 | 4337 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2020 | 1962 | 0.02 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Minority Groups | 1 | 2017 | 1631 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2019 | 51949 | 0.02 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.02 | Why? |
| Remote Consultation | 1 | 2020 | 2396 | 0.02 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.02 | Why? |
| Liver Diseases | 1 | 2020 | 2698 | 0.02 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2017 | 3493 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Clinical Competence | 1 | 2017 | 3263 | 0.02 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2020 | 4741 | 0.01 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.01 | Why? |
| Obesity | 1 | 2020 | 7388 | 0.01 | Why? |
| Travel | 1 | 2018 | 7220 | 0.01 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |